ARTICLE | Company News
AmBisome gets expanded label
July 5, 2000 7:00 AM UTC
Gilead (GILD) and partner Fujisawa (Deerfield, Ill.) received FDA marketing approval for AmBisome amphotericin B for the treatment of cryptococcal meningitis in HIV-infected patients. Fujisawa submitt...